Search research articles
Contact Us
Filters
Showing results (421-430 of 522) with videos related to
Page
of 53
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
BMJ Open
|
December 1, 2021
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol
Jeroen H A Creemers, Inka Pawlitzky, Konstantina Grosios, et al.
Organic & Biomolecular Chemistry
|
February 20, 2019
Glycoconjugate synthesis using chemoselective ligation
Shuihong Cheng, Paeton L Wantuch, Megan E Kizer, et al.
British Journal of Cancer
|
October 7, 2016
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt
Avinash Gupta, Corran Roberts, Finn Tysoe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
R S Midgley, D J Kerr, K T Flaherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
A Gupta, S Love, A Schuh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors
Malcolm Ranson, Mark R Middleton, John Bridgewater, et al.
British Journal of Cancer
|
February 18, 2011
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
O A Khan, M Gore, P Lorigan, et al.
Pilot and Feasibility Studies
|
October 22, 2020
A community feasibility study of a cooking behavior intervention in African-American adults at risk for cardiovascular disease: DC COOKS (DC Community Organizing for Optimal culinary Knowledge Study) with Heart
Nicole Farmer, Tiffany M Powell-Wiley, Kimberly R Middleton, et al.
BMJ Health & Care Informatics
|
August 25, 2020
Time to listen: a mixed-method study examining community-based views of mobile technology for interventions to promote physical activity
Sophie E Claudel, Joniqua N Ceasar, Marcus R Andrews, et al.
Page
of 53
Search research articles
Search
Showing results (421-430 of 522) with videos related to
Sort By:
Page
of 53
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2015
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline
Alexander Stratigos, Claus Garbe, Celeste Lebbe, et al.
BMJ Open
|
December 1, 2021
Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol
Jeroen H A Creemers, Inka Pawlitzky, Konstantina Grosios, et al.
Organic & Biomolecular Chemistry
|
February 20, 2019
Glycoconjugate synthesis using chemoselective ligation
Shuihong Cheng, Paeton L Wantuch, Megan E Kizer, et al.
British Journal of Cancer
|
October 7, 2016
RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt
Avinash Gupta, Corran Roberts, Finn Tysoe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 12, 2007
A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan
R S Midgley, D J Kerr, K T Flaherty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
A Gupta, S Love, A Schuh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2006
Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors
Malcolm Ranson, Mark R Middleton, John Bridgewater, et al.
British Journal of Cancer
|
February 18, 2011
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours
O A Khan, M Gore, P Lorigan, et al.
Pilot and Feasibility Studies
|
October 22, 2020
A community feasibility study of a cooking behavior intervention in African-American adults at risk for cardiovascular disease: DC COOKS (DC Community Organizing for Optimal culinary Knowledge Study) with Heart
Nicole Farmer, Tiffany M Powell-Wiley, Kimberly R Middleton, et al.
BMJ Health & Care Informatics
|
August 25, 2020
Time to listen: a mixed-method study examining community-based views of mobile technology for interventions to promote physical activity
Sophie E Claudel, Joniqua N Ceasar, Marcus R Andrews, et al.
Page
of 53